In these models, we found that inhibition of IL1R1 did not affect primary tumour growth (Fig. 1a, b), whereas inhibition of IL-1B resulted in increased primary tumour growth (Fig. 1c, d), therefore recapitulating the effect that we had previously seen following pharmacological inhibition of IL-1B signalling11. This evidence concerns the gene IL1B and neoplasm.